Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema ; volume:44 ; number:1 ; day:25 ; month:6 ; year:2024 ; pages:1-8 ; date:12.2024
International ophthalmology ; 44, Heft 1 (25.6.2024), 1-8, 12.2024
- Urheber
-
Pichi, Francesco
Abdi, Abdulhamid
Aljneibi, Shaikha
El Ghrably, Ibraheem
Agarwal, Aniruddha
Ghazi, Nicola G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10792-024-03226-2
- URN
-
urn:nbn:de:101:1-2409152111479.970256296168
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pichi, Francesco
- Abdi, Abdulhamid
- Aljneibi, Shaikha
- El Ghrably, Ibraheem
- Agarwal, Aniruddha
- Ghazi, Nicola G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product